Bicycle Therapeutics Stock Price Patterns

BCYC Stock  USD 6.52  0.10  1.56%   
At the present time, the RSI of Bicycle Therapeutics' share price is approaching 43 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bicycle Therapeutics, making its price go up or down.

Momentum 43

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Bicycle Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Bicycle Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Bicycle Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(1.03)
EPS Estimate Current Year
(3.87)
EPS Estimate Next Year
(3.48)
Wall Street Target Price
21.5
EPS Estimate Current Quarter
(1.03)
Using Bicycle Therapeutics hype-based prediction, you can estimate the value of Bicycle Therapeutics from the perspective of Bicycle Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Bicycle Therapeutics using Bicycle Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Bicycle using crowd psychology based on the activity and movement of Bicycle Therapeutics' stock price.

Bicycle Therapeutics Implied Volatility

    
  2.51  
Bicycle Therapeutics' implied volatility exposes the market's sentiment of Bicycle Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bicycle Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bicycle Therapeutics stock will not fluctuate a lot when Bicycle Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Bicycle Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Bicycle because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bicycle Therapeutics after-hype prediction price

    
  USD 6.51  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Bicycle contract

Based on the Rule 16, the options market is currently suggesting that Bicycle Therapeutics will have an average daily up or down price movement of about 0.16% per day over the life of the 2026-03-20 option contract. With Bicycle Therapeutics trading at USD 6.52, that is roughly USD 0.0102 . If you think that the market is fully incorporating Bicycle Therapeutics' daily price movement you should consider acquiring Bicycle Therapeutics options at the current volatility level of 2.51%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Bicycle Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bicycle Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
5.8710.0913.55
Details
Naive
Forecast
LowNextHigh
2.906.369.82
Details
13 Analysts
Consensus
LowTargetHigh
19.5721.5023.87
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.1-0.87-0.61
Details

Bicycle Therapeutics After-Hype Price Density Analysis

As far as predicting the price of Bicycle Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bicycle Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bicycle Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bicycle Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Bicycle Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bicycle Therapeutics' historical news coverage. Bicycle Therapeutics' after-hype downside and upside margins for the prediction period are 3.05 and 9.97, respectively. We have considered Bicycle Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
6.52
6.51
After-hype Price
9.97
Upside
Bicycle Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Bicycle Therapeutics is based on 3 months time horizon.

Bicycle Therapeutics Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Bicycle Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bicycle Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bicycle Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.11 
3.46
  0.01 
  0.03 
8 Events / Month
6 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
6.52
6.51
0.15 
2,662  
Notes

Bicycle Therapeutics Hype Timeline

Bicycle Therapeutics is currently traded for 6.52. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.03. Bicycle is anticipated to decline in value after the next headline, with the price expected to drop to 6.51. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.15%, whereas the daily expected return is currently at -0.11%. The volatility of related hype on Bicycle Therapeutics is about 1510.92%, with the expected price after the next announcement by competition of 6.49. About 79.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bicycle Therapeutics recorded a loss per share of 3.62. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Bicycle Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.

Bicycle Therapeutics Related Hype Analysis

Having access to credible news sources related to Bicycle Therapeutics' direct competition is more important than ever and may enhance your ability to predict Bicycle Therapeutics' future price movements. Getting to know how Bicycle Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bicycle Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RAPTRAPT Therapeutics(2.21)6 per month 3.04  0.14  7.87 (6.78) 64.05 
NMRANeumora Therapeutics(0.11)7 per month 0.00 (0.05) 9.77 (7.30) 33.25 
OMEROmeros 0.60 7 per month 4.49  0.09  12.62 (7.99) 87.69 
LXRXLexicon Pharmaceuticals 0.03 9 per month 4.31  0.02  9.86 (7.65) 31.36 
KALVKalvista Pharmaceuticals(0.01)10 per month 3.11  0.13  8.43 (5.92) 25.15 
ADCTADC Therapeutics SA 0.03 11 per month 0.00 (0.04) 8.49 (7.06) 22.84 
PRTAProthena plc(0.04)7 per month 0.00 (0.04) 5.10 (4.36) 13.99 
FDMT4D Molecular Therapeutics 0.37 9 per month 0.00 (0.08) 6.52 (9.30) 27.09 
FULCFulcrum Therapeutics(0.76)16 per month 4.57  0.05  11.56 (7.84) 53.80 
CMPXCompass Therapeutics(0.19)8 per month 3.01  0.18  7.61 (5.34) 16.90 

Bicycle Therapeutics Additional Predictive Modules

Most predictive techniques to examine Bicycle price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bicycle using various technical indicators. When you analyze Bicycle charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bicycle Therapeutics Predictive Indicators

The successful prediction of Bicycle Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bicycle Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bicycle Therapeutics based on analysis of Bicycle Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bicycle Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bicycle Therapeutics's related companies.
 2023 2024 2025 2026 (projected)
Current Ratio8.0813.8112.437.03
Net Debt To EBITDA2.635.284.752.73

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Bicycle Stock analysis

When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Managers
Screen money managers from public funds and ETFs managed around the world